Company · CIK 1822929

# Eucrates Biomedical Acquisition Corp.

| CIK | [1822929](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001822929) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 6770 — Blank Checks |
| Incorporated in | D8 |
| Business address | NY |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2020-12-07 |

## Offerings

 1 registration

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-249333 | SPAC Final prospectus | 2020-10-06 | 2020-10-26 | 5 |

## Filings

 6

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2020-10-26 | [424B4](https://www.sec.gov/Archives/edgar/data/1822929/000110465920118165/0001104659-20-118165-index.htm) Final prospectus | 333-249333 | 0001104659-20-118165 |
| 2020-10-23 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1822929/999999999520002965/9999999995-20-002965-index.htm) Declared effective | 333-249333 | 9999999995-20-002965 |
| 2020-10-21 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1822929/000110465920116715/0001104659-20-116715-index.htm) Amendment | 333-249333 | 0001104659-20-116715 |
| 2020-10-15 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1822929/000110465920115329/0001104659-20-115329-index.htm) Amendment | 333-249333 | 0001104659-20-115329 |
| 2020-10-06 | [S-1](https://www.sec.gov/Archives/edgar/data/1822929/000110465920112311/0001104659-20-112311-index.htm) Registration filed | 333-249333 | 0001104659-20-112311 |
| 2020-09-02 | [DRS](https://www.sec.gov/Archives/edgar/data/1822929/000110465920101557/0001104659-20-101557-index.htm) Draft made public | 377-03487 | 0001104659-20-101557 |

[All filings of this company](https://equitycapital.markets/filings?cik=1822929) · [CSV](https://equitycapital.markets/filings.csv?cik=1822929)

---
Source page: https://equitycapital.markets/company/1822929 · Data: U.S. SEC EDGAR · CC BY 4.0